Vvax001 Cancer Vaccine in Premalignant Cervical Lesions - Phase II

Conditions:   CIN3;   Cervical Intraepithelial Neoplasia;   Cervical Intraepithelial Neoplasia Grade 3;   HPV 16 Infection Intervention:   Biological: Vvax001 therapeutic cancer vaccine Sponsors:   University Medical Center Groningen;   Dutch Cancer Society;   ViciniVax B.V Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials